SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-04-004156
Filing Date
2004-11-09
Accepted
2004-11-08 18:38:17
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS INC. FORM 10-Q w68368e10vq.htm 10-Q 483548
2 DIRECTOR STOCK UNIT AGREEMENT w68368exv10w43.htm EX-10.43 13319
3 CERTIFICATION OF CEO w68368exv31w1.htm EX-31.1 7799
4 CERTIFICATION OF CFO w68368exv31w2.htm EX-31.2 8264
5 CERTIFICATION OF CEO w68368exv32w1.htm EX-32.1 3267
6 CERTIFICATION OF CFO w68368exv32w2.htm EX-32.2 3291
  Complete submission text file 0000950133-04-004156.txt   521559
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 041127064
SIC: 2834 Pharmaceutical Preparations